Current Genomics Achieves JCR Q2 Rankings with 2025 Impact Factor of 4.0
Published 10 July, 2026
Following the release of the 2025 Journal Citation Reports on June 17, 2026, Current Genomics (CG) has reached a significant milestone, with its Impact Factor rising to 4.0. This marks a substantial elevation in the journal's scholarly influence and international recognition within the life sciences.
In the Biochemistry & Molecular Biology category, CG now ranks 140th out of 328 journals, securing a Q2 position. Meanwhile, in the Genetics & Heredity category, the journal ranks 53rd out of 192, also attaining Q2 status. These concurrent top-quartile placements across both disciplines reflect the journal's broad-based academic advancement and its growing visibility on the global stage. The dual Q2 rankings underscore CG's sustained performance and strengthening reputation in the rapidly evolving field of genomics and molecular biosciences.
The editorial team extends its sincere gratitude to the dedicated board members, rigorous reviewers, insightful authors, and engaged readers. Looking forward, Current Genomics remains steadfast in its mission to advance genomic research and to further elevate its international standing. The journal will continue to serve as a premier platform for disseminating high-impact discoveries, fostering interdisciplinary collaboration, and contributing to the global knowledge base in genomics and related disciplines.